Professor Teng and his team will initially test whether their device can accurately detect and measure CMV directly in samples taken from newborn babies. They will then compare the results against the current gold standard diagnostic test to demonstrate the feasibility of using it as a screening tool for CMV infection in the future.
If successful, the availability of an accurate, easy-to-use diagnostic tool could transform lives by allowing early detection of CMV in more babies, enabling prompt treatment to help limit long-term disability.
TOGETHER WE CAN HELP PROTECT BABIES
100% of your donation will support researchers developing a CMV screening device for babies.